期刊文献+

726例血铅超标临床驱铅试验研究

Experimental Study on 726 Cases of Blood Lead Exceed the Standard in Clinical Removing Lead
下载PDF
导出
摘要 目的分析和讨论血铅超标临床驱铅试验研究。方法随机抽取2010年1月~2012年12月我院收治的血铅超标临床患者726例,分成依地酸二钠钙0.5g肌肉注射组和依地酸二钠钙1.0g静脉滴注组,对两组患者的治疗效果进行观察分析。结果两组患者治疗后血铅浓度、ZPP以及尿铅水平差异无统计学意义(P〉0.05),两组患者的疗程、住院时间差异显著(P〈0.05)。结论对血铅超标患者采取依地酸二钠钙进行治疗的临床疗效显著,肌肉注射与静脉滴注效果无明显差异,值得关注。 Objective Experimental study of blood lead exceed the standard in clinical removing lead test results are analyzed and discussed.Methods 726 patients with blood lead exceed the standard were randomly selected admitted to our hospital from 2010 January to 2012 December,according to treatment methods into calcium EDTA 0.5g intramuscular injection group and calcium EDTA 1.0g intravenous infusion group,observation and analysis were carried out on two groups of patients.Results There were no significant in two groups of patients after treatment,blood lead concentration,ZPP and urine lead level difference(P〉0.05),two groups of patients with treatment,hospitalization time difference was significant(P〈0.05).Conclusion The effect of calcium EDTA in patients with blood lead exceed the standard was curative significantly,no significant difference between the intramuscular injection and intravenous drip effect,it is worthy of attention.
出处 《现代诊断与治疗》 CAS 2013年第6期1208-1209,共2页 Modern Diagnosis and Treatment
关键词 依地酸二钠钙 血铅超标 临床驱铅 效果 Calcium EDTA Blood lead exceed the standard Clinical removing lead Effect
  • 相关文献

参考文献4

二级参考文献22

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部